These prominent drugs, including Semaglutide, are belonging to a group of treatments called GLP-1 target agonists. Fundamentally, GLP-1 is a body's own hormone that helps regulate glucose levels and encourages feelings of satiety, potentially can contribute to a reduction in weight. Semaglutide i